{"altmetric_id":21548562,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Janssen R&D Ireland"],"first_seen_on":"2017-07-06T14:59:47+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1383827760,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01466790"],"nct_id":"NCT01466790","pubdate":"2011-11-03T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon\/Ribavirin Therapy or HCV Treatment-Naive Patients (COSMOS)","type":"clinical_trial_study_record"},"altmetric_score":{"score":5.248,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.248},"context_for_score":{"all":{"total_number_of_other_articles":7994338,"mean":6.7425387846365,"rank":1447622,"this_scored_higher_than_pct":81,"this_scored_higher_than":6546371,"rank_type":"exact","sample_size":7994338,"percentile":81},"similar_age_3m":{"total_number_of_other_articles":104566,"mean":10.920155558744,"rank":23452,"this_scored_higher_than_pct":77,"this_scored_higher_than":81114,"rank_type":"exact","sample_size":104566,"percentile":77},"this_journal":{"total_number_of_other_articles":22217,"mean":10.401083903493,"rank":5926,"this_scored_higher_than_pct":73,"this_scored_higher_than":16288,"rank_type":"exact","sample_size":22217,"percentile":73},"similar_age_this_journal_3m":{"total_number_of_other_articles":267,"mean":2.6494360902256,"rank":16,"this_scored_higher_than_pct":94,"this_scored_higher_than":251,"rank_type":"exact","sample_size":267,"percentile":94}}},"demographics":[],"counts":{"total":{"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[55658],"posts_count":1}},"posts":{"blogs":[{"title":"Gilead Vs. Challengers In The Hepatitis C Race","url":"http:\/\/hepatitiscresearchandnewsupdates.blogspot.com\/2013\/11\/gilead-vs-challengers-in-hepatitis-c.html","citation_ids":[4692072,21548559,21548562,4689628,4694217,21548565,21548566],"posted_on":"2013-11-07T12:36:00+00:00","summary":"Provided by Seeking Alpha  Nov 7 2013, 07:00&#160; |&#160; about: GILD, includes: ABBV, BMY, JNJ, MRK  Peter Geschek    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this a","author":{"name":"HCV Research and News","url":"http:\/\/hepatitiscresearchandnewsupdates.blogspot.com\/","description":""}}]}}